Capecitabine: A review
Top Cited Papers
- 1 January 2005
- journal article
- review article
- Published by Elsevier in Clinical Therapeutics
- Vol. 27 (1) , 23-44
- https://doi.org/10.1016/j.clinthera.2005.01.005
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- A phase II trial of capecitabine in heavily pre-treated platinum-resistant ovarian cancerGynecologic Oncology, 2004
- New systemic frontline treatment for metastatic colorectal carcinomaCancer, 2004
- Oral capecitabine in anthracycline- and taxane-pretreated advanced/metastatic breast cancerActa Oncologica, 2004
- Multicentre, phase II study evaluating capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancerEuropean Journal Of Cancer, 2004
- Phase II Study of Oral Capecitabine in Patients With Advanced or Metastatic Pancreatic CancerJournal of Clinical Oncology, 2002
- Clinical Pharmacokinetics of CapecitabineClinical Pharmacokinetics, 2001
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000
- Cardiotoxicity of the Antiproliferative Compound FluorouracilDrugs, 1999
- Prospective randomised trial comparing fluorouracil versus doxifluridine for the treatment of advanced colorectal cancerEuropean Journal Of Cancer, 1993
- Tumor inhibitory effects of a new fluorouracil derivative: 5′-deoxy-5-fluorouridinePublished by Elsevier ,1980